Please Wait
Applying Filters...
menu
    • menu
    Inabata France-PSE
    News
    Lilly lands next-gen pain asset in $1B SiteOne acquisition

    28 May 2025

    // REUTERS

    Savara's Lung Disease Asset Hit with FDA Refuse-To-File Letter

    28 May 2025

    // FIERCE PHARMA

    Sanofi Exploring Vaccine Production in Vietnam with Local Partner

    28 May 2025

    // REUTERS

    Data Compilation
    #PharmaFlow

    Pharmasynthese

    Contact Supplier

    Website

    Pharmacy Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
    Left Arrow
    Right Arrow
    Related CompaniesRelated Companies

    About

    INABATA Group is a network of 60 subsidiaries in 20 countries worldwide, and overseas sales account for over 50% of consolidated net sales. Inabata France was founded in 1990, at first, to support chemical and pharmaceutical products exportation to Japan. Then Pharmasynthese was acquired in 2006, leading to internalization of a production site which is specialized in chemical synthesis. Today, Inabata/Pharmasynthese offers a wide variety of services including sourcing, manufacturing and development of raw materials mainly for pharmaceutic and cosmetic use.